Literature DB >> 12808286

Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation.

Binbin Li1, Shifeng Yu.   

Abstract

UNLABELLED: Genistein, a soybean-derived isoflavone, has been shown to suppress osteoclastic bone resorption. To clarify the mechanisms underlying this action, we investigated the effects of genistein on the differentiation, cytoskeleton and function in mice osteoclasts in vitro and bone metabolism in ovariectomized rats. STUDY
DESIGN: Primary OCs were isolated from 3 week-old mice and induced by 1,25(OH)(2)D(3). Then OCs were exposed to genistein at various concentration of 0 M, 10(-9) M, 10(-8) M, 10(-7) M, 10(-6) M, and 10(-5) M. The number of TRAP+ cells were counted as well as the surface area of bone resorption on bone slice. F-actin change was observed by Confocal. In vivo, forty 12 week-old female SD rats were randomly assigned to four groups: (1) sham operated (Sham); (2) (OVX); (3) ovariectomized and treated with estradiol (OVX-E); (4) ovariectomized and received genistein (OVX-G). After 12 weeks, BMD, body weight, serum level of alkaline phosphatase (ALP), acid phosphatase (ACP), osteocalcin (OC), IL-1beta, TNFalpha, IL-6 and calcitonin (CT) were evaluated. Femur were sectioned. In addition, the serum estradiol, the weight of uteri and histological behavior were also examined to indicate the side effect of genistein to the uteri.
RESULTS: In vitro, the number of TRAP+ cells decreased depending on the concentration of genistein as well as the area of bone resorption. F-actin became disorder under Confocal. In vivo, after treated with genistein, BMD and the serum level of ALP, ACP, osteocalcin increased significantly, while the serum level of IL-1beta and TNFalpha decreased. Especially, the increase of ALP and osteocalcin of OVX-G was higher than that of OVX-E. Histologically, the pachy-trabecula were observed as well as the more mineral deposition lines. Additionally, the uterus weight index and the serum estradiol in OVX-G rats were lower significantly than those of OVX-E. The epithelia of uteri gland in OVX-G appeared cubic while those of OVX-E became squamous.
CONCLUSIONS: Genistein can prevent bone resorption diseases by the promotion of bone formation and the prevention of bone resorption with slight side effect.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12808286     DOI: 10.1248/bpb.26.780

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  20 in total

1.  Combined intervention of dietary soybean proteins and swim training: effects on bone metabolism in ovariectomized rats.

Authors:  Hélène Figard; Fabienne Mougin; Vincent Gaume; Alain Berthelot
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

Review 2.  The pros and cons of phytoestrogens.

Authors:  Heather B Patisaul; Wendy Jefferson
Journal:  Front Neuroendocrinol       Date:  2010-03-27       Impact factor: 8.606

3.  Effects of different doses of ferutinin on bone formation/resorption in ovariectomized rats.

Authors:  Francesco Cavani; Marzia Ferretti; Gianluca Carnevale; Laura Bertoni; Manuela Zavatti; Carla Palumbo
Journal:  J Bone Miner Metab       Date:  2012-07-25       Impact factor: 2.626

4.  Role of phytoestrogenic oils in alleviating osteoporosis associated with ovariectomy in rats.

Authors:  Hanaa A Hassan; Azza M El Wakf; Nermin E El Gharib
Journal:  Cytotechnology       Date:  2012-11-18       Impact factor: 2.058

5.  Dose-dependent effects of genistein on bone homeostasis in rats' mandibular subchondral bone.

Authors:  Yong-qi Li; Xiang-hui Xing; Hui Wang; Xi-li Weng; Shi-bin Yu; Guang-ying Dong
Journal:  Acta Pharmacol Sin       Date:  2011-11-28       Impact factor: 6.150

6.  Possible antiosteoporotic mechanism of Cicer arietinum extract in ovariectomized rats.

Authors:  Sohair R Fahmy; Amel M Soliman; Amany A Sayed; Mohamed Marzouk
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

7.  The antidepressant bupropion exerts alleviating properties in an ovariectomized osteoporotic rat model.

Authors:  Hatem M Abuohashish; Mohammed M Ahmed; Salim S Al-Rejaie; Kamal E H Eltahir
Journal:  Acta Pharmacol Sin       Date:  2014-12-29       Impact factor: 6.150

8.  Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorption.

Authors:  Mette G Sørensen; Morten A Karsdal; Morten H Dziegiel; Jean A Boutin; Olivier Nosjean; Kim Henriksen
Journal:  BMC Musculoskelet Disord       Date:  2010-10-26       Impact factor: 2.362

Review 9.  Soy Isoflavones and Osteoporotic Bone Loss: A Review with an Emphasis on Modulation of Bone Remodeling.

Authors:  Xi Zheng; Sun-Kyeong Lee; Ock K Chun
Journal:  J Med Food       Date:  2015-12-15       Impact factor: 2.786

Review 10.  Natural Medicinal Compounds in Bone Tissue Engineering.

Authors:  Susmita Bose; Naboneeta Sarkar
Journal:  Trends Biotechnol       Date:  2019-12-25       Impact factor: 19.536

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.